MDR-001
Sponsors
MindRank AI Ltd
Conditions
ObesityObesity &Amp; OverweightOverweight and Obese VolunteersOverweight and ObesityOverweight or Obesity
Phase 1
A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants
RecruitingNCT06778850
Start: 2023-06-09End: 2025-12-30Target: 131Updated: 2025-03-07
Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight
Not yet recruitingNCT07110766
Start: 2025-08-09End: 2025-10-30Target: 24Updated: 2025-08-08